Intermolecular, Inc.
IMI
IMI was delisted on the 19th of September, 2019.
20 hedge funds and large institutions have $19M invested in Intermolecular, Inc. in 2017 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 5 closing their positions.
9% more capital invested
Capital invested by funds: $17.4M → $19M (+$1.56M)
0.41% less ownership
Funds ownership: 37.96% → 37.55% (-0.41%)
13% less funds holding
Funds holding: 23 → 20 (-3)
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
80% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$17K |
| 2 |
ISL
Ingalls & Snyder LLC
New York
|
+$9.42K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$18 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AL
Aspiriant LLC
Los Angeles,
California
|
-$61K |
| 2 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$45K |
| 3 |
SIM
Spark Investment Management
New York
|
-$37.5K |
| 4 |
SKK
Shepherd Kaplan Krochuk
Boston,
Massachusetts
|
-$25K |
| 5 |
BlackRock
New York
|
-$15.4K |
IMI Hedge Fund Activity: Q3 2017 in Review
20 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Intermolecular, Inc. (IMI) for Q3 2017, worth a combined $19M — up 8.9% from $17.4M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of IMI and 2 opened new positions — a net loss of 3 holders — while 5 trimmed existing stakes and 1 added.
The largest buyer was Renaissance Technologies, adding an estimated $17K. The largest seller was Aspiriant LLC, exiting entirely with an estimated $61K sold.
- 20 institutional investors held Intermolecular, Inc. (IMI) as of Q3 2017, down from 23 in Q2 2017.
- Funds reported $19M of Intermolecular, Inc. stock for Q3 2017, up 8.9% quarter-over-quarter.
- 2 funds opened new Intermolecular, Inc. positions in Q3 2017 and 5 closed out, a net change of -3 holders.
- The largest Intermolecular, Inc. buyer in Q3 2017 was Renaissance Technologies, an estimated $17K added.
- The largest Intermolecular, Inc. seller in Q3 2017 was Aspiriant LLC, an estimated $61K sold.
Based on aggregated 13F filings for Q3 2017.